| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 230 | 2024 | 4285 | 17.050 |
Why?
|
| Particulate Matter | 113 | 2023 | 2529 | 10.230 |
Why?
|
| Air Pollution | 71 | 2023 | 2286 | 7.870 |
Why?
|
| Environmental Exposure | 114 | 2023 | 4232 | 7.870 |
Why?
|
| Air Pollutants | 75 | 2023 | 2816 | 7.820 |
Why?
|
| Environmental Pollutants | 49 | 2023 | 1179 | 7.390 |
Why?
|
| Epigenesis, Genetic | 118 | 2024 | 3646 | 7.280 |
Why?
|
| DNA, Mitochondrial | 31 | 2023 | 817 | 6.070 |
Why?
|
| Maternal Exposure | 34 | 2022 | 961 | 5.270 |
Why?
|
| Occupational Exposure | 39 | 2023 | 1793 | 4.920 |
Why?
|
| Fetal Blood | 34 | 2022 | 1318 | 3.910 |
Why?
|
| Telomere | 23 | 2023 | 910 | 3.730 |
Why?
|
| Aging | 78 | 2024 | 8664 | 3.730 |
Why?
|
| Long Interspersed Nucleotide Elements | 30 | 2019 | 338 | 3.580 |
Why?
|
| MicroRNAs | 46 | 2024 | 3751 | 3.550 |
Why?
|
| Lead | 14 | 2022 | 852 | 3.490 |
Why?
|
| Inhalation Exposure | 21 | 2017 | 443 | 3.300 |
Why?
|
| Leukocytes | 35 | 2022 | 2045 | 3.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 34 | 2022 | 2408 | 3.130 |
Why?
|
| Epigenomics | 31 | 2023 | 903 | 3.020 |
Why?
|
| Air Pollutants, Occupational | 12 | 2016 | 408 | 2.790 |
Why?
|
| Phthalic Acids | 12 | 2022 | 436 | 2.730 |
Why?
|
| CpG Islands | 51 | 2023 | 1170 | 2.580 |
Why?
|
| Vehicle Emissions | 10 | 2016 | 665 | 2.300 |
Why?
|
| Alu Elements | 17 | 2016 | 119 | 2.210 |
Why?
|
| Pregnancy | 130 | 2024 | 29144 | 2.090 |
Why?
|
| Soot | 13 | 2019 | 232 | 2.000 |
Why?
|
| Endocrine Disruptors | 8 | 2019 | 237 | 1.860 |
Why?
|
| Benzene | 7 | 2017 | 100 | 1.800 |
Why?
|
| Arsenic | 17 | 2024 | 328 | 1.790 |
Why?
|
| Metals | 13 | 2022 | 719 | 1.680 |
Why?
|
| Mexico | 30 | 2022 | 689 | 1.670 |
Why?
|
| Meconium | 4 | 2020 | 48 | 1.630 |
Why?
|
| Placenta | 19 | 2023 | 1699 | 1.630 |
Why?
|
| Promoter Regions, Genetic | 26 | 2019 | 5867 | 1.560 |
Why?
|
| Humans | 522 | 2024 | 744366 | 1.550 |
Why?
|
| Birth Weight | 15 | 2021 | 2069 | 1.490 |
Why?
|
| Veterans | 12 | 2022 | 2519 | 1.450 |
Why?
|
| Carbon | 9 | 2024 | 687 | 1.410 |
Why?
|
| Male | 310 | 2024 | 350115 | 1.380 |
Why?
|
| Mitochondria | 13 | 2023 | 3514 | 1.360 |
Why?
|
| Mercury | 5 | 2022 | 285 | 1.310 |
Why?
|
| Fetal Development | 9 | 2021 | 767 | 1.290 |
Why?
|
| Italy | 26 | 2015 | 832 | 1.270 |
Why?
|
| Female | 306 | 2024 | 380193 | 1.230 |
Why?
|
| Acetaminophen | 3 | 2022 | 545 | 1.220 |
Why?
|
| Blood Coagulation | 7 | 2017 | 1127 | 1.200 |
Why?
|
| Cognition | 14 | 2022 | 6770 | 1.200 |
Why?
|
| Blood Pressure | 26 | 2021 | 8551 | 1.190 |
Why?
|
| Inflammation | 21 | 2024 | 10637 | 1.160 |
Why?
|
| Adult | 203 | 2024 | 214052 | 1.130 |
Why?
|
| Environmental Monitoring | 16 | 2024 | 1414 | 1.130 |
Why?
|
| Temperature | 9 | 2023 | 2204 | 1.110 |
Why?
|
| Flame Retardants | 4 | 2024 | 87 | 1.110 |
Why?
|
| Lung | 14 | 2023 | 9857 | 1.100 |
Why?
|
| Environmental Health | 5 | 2022 | 278 | 1.090 |
Why?
|
| Oxidative Stress | 18 | 2021 | 3084 | 1.080 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 8 | 2016 | 798 | 1.060 |
Why?
|
| Gene Dosage | 5 | 2020 | 1252 | 1.050 |
Why?
|
| Pesticides | 8 | 2022 | 287 | 1.040 |
Why?
|
| Particle Size | 17 | 2019 | 1642 | 1.040 |
Why?
|
| Maternal-Fetal Exchange | 6 | 2021 | 456 | 1.000 |
Why?
|
| Steel | 4 | 2013 | 26 | 0.990 |
Why?
|
| Heart Rate | 8 | 2017 | 4092 | 0.980 |
Why?
|
| Aged | 160 | 2024 | 163288 | 0.980 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2022 | 816 | 0.970 |
Why?
|
| Metallurgy | 5 | 2014 | 94 | 0.960 |
Why?
|
| Cardiovascular Diseases | 30 | 2023 | 15160 | 0.960 |
Why?
|
| Longevity | 6 | 2023 | 1071 | 0.960 |
Why?
|
| Gestational Age | 18 | 2021 | 3493 | 0.960 |
Why?
|
| DNA | 17 | 2020 | 7294 | 0.950 |
Why?
|
| Cohort Studies | 66 | 2023 | 40559 | 0.950 |
Why?
|
| Cervix Uteri | 6 | 2020 | 590 | 0.940 |
Why?
|
| Occupational Diseases | 9 | 2016 | 1469 | 0.920 |
Why?
|
| Milk, Human | 5 | 2023 | 490 | 0.910 |
Why?
|
| Vitamin B 6 | 6 | 2021 | 237 | 0.910 |
Why?
|
| DNA Damage | 8 | 2017 | 2432 | 0.890 |
Why?
|
| Smoking | 27 | 2020 | 8987 | 0.890 |
Why?
|
| Tandem Repeat Sequences | 2 | 2014 | 185 | 0.870 |
Why?
|
| Nasal Mucosa | 5 | 2021 | 373 | 0.870 |
Why?
|
| Infant, Newborn | 56 | 2023 | 25628 | 0.860 |
Why?
|
| Asthma | 16 | 2023 | 6010 | 0.860 |
Why?
|
| Genome-Wide Association Study | 30 | 2023 | 12262 | 0.850 |
Why?
|
| Middle Aged | 155 | 2024 | 213390 | 0.840 |
Why?
|
| Metals, Heavy | 5 | 2021 | 139 | 0.840 |
Why?
|
| Histones | 11 | 2017 | 2598 | 0.840 |
Why?
|
| Stomach Neoplasms | 10 | 2011 | 1332 | 0.840 |
Why?
|
| Endogenous Retroviruses | 1 | 2023 | 112 | 0.830 |
Why?
|
| Receptors, Glucocorticoid | 5 | 2020 | 302 | 0.810 |
Why?
|
| Metabolic Diseases | 4 | 2023 | 658 | 0.800 |
Why?
|
| Child | 81 | 2024 | 77709 | 0.800 |
Why?
|
| Folic Acid | 10 | 2022 | 1300 | 0.800 |
Why?
|
| DNA Adducts | 2 | 2013 | 93 | 0.790 |
Why?
|
| Aged, 80 and over | 75 | 2023 | 57776 | 0.780 |
Why?
|
| Stress, Psychological | 10 | 2024 | 4245 | 0.780 |
Why?
|
| Lymphocyte Count | 2 | 2020 | 793 | 0.750 |
Why?
|
| Diabetes, Gestational | 6 | 2020 | 1184 | 0.750 |
Why?
|
| Humidity | 2 | 2019 | 197 | 0.740 |
Why?
|
| Young Adult | 66 | 2023 | 56429 | 0.730 |
Why?
|
| Follicular Fluid | 6 | 2023 | 87 | 0.730 |
Why?
|
| Cooking | 2 | 2019 | 313 | 0.730 |
Why?
|
| China | 14 | 2023 | 2245 | 0.720 |
Why?
|
| Oogenesis | 3 | 2019 | 131 | 0.720 |
Why?
|
| Prospective Studies | 57 | 2023 | 53290 | 0.710 |
Why?
|
| Coke | 3 | 2023 | 21 | 0.710 |
Why?
|
| Linear Models | 21 | 2021 | 5953 | 0.700 |
Why?
|
| Fetal Growth Retardation | 4 | 2018 | 570 | 0.690 |
Why?
|
| Longitudinal Studies | 33 | 2023 | 13991 | 0.690 |
Why?
|
| Vitamin B 12 | 6 | 2021 | 527 | 0.690 |
Why?
|
| Body Mass Index | 26 | 2023 | 12721 | 0.690 |
Why?
|
| Extraction and Processing Industry | 3 | 2014 | 10 | 0.690 |
Why?
|
| Bone Density | 2 | 2023 | 3468 | 0.670 |
Why?
|
| Halogenated Diphenyl Ethers | 4 | 2024 | 77 | 0.670 |
Why?
|
| Dioxins | 6 | 2020 | 102 | 0.670 |
Why?
|
| Environmental Illness | 2 | 2019 | 34 | 0.670 |
Why?
|
| Radioactivity | 1 | 2019 | 63 | 0.660 |
Why?
|
| Sequence Analysis, DNA | 19 | 2021 | 4805 | 0.660 |
Why?
|
| DNA, Neoplasm | 5 | 2015 | 1758 | 0.660 |
Why?
|
| Hot Temperature | 4 | 2019 | 1356 | 0.660 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2019 | 534 | 0.660 |
Why?
|
| Ozone | 6 | 2023 | 469 | 0.640 |
Why?
|
| Embryo Implantation | 2 | 2021 | 272 | 0.630 |
Why?
|
| Bayes Theorem | 15 | 2022 | 2307 | 0.630 |
Why?
|
| Premature Birth | 7 | 2022 | 1721 | 0.600 |
Why?
|
| Xenobiotics | 1 | 2017 | 73 | 0.600 |
Why?
|
| Hypertension | 12 | 2021 | 8479 | 0.600 |
Why?
|
| Sulfates | 6 | 2016 | 390 | 0.590 |
Why?
|
| Phenols | 6 | 2019 | 497 | 0.580 |
Why?
|
| Public Health | 6 | 2019 | 2602 | 0.580 |
Why?
|
| Leukocyte Count | 2 | 2020 | 1588 | 0.580 |
Why?
|
| Cytosine | 2 | 2015 | 216 | 0.570 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 81 | 0.570 |
Why?
|
| Fertilization in Vitro | 9 | 2023 | 1284 | 0.560 |
Why?
|
| Blood Glucose | 9 | 2021 | 6254 | 0.560 |
Why?
|
| Vitamin B Complex | 2 | 2017 | 288 | 0.560 |
Why?
|
| Nitrogen Oxides | 1 | 2016 | 129 | 0.560 |
Why?
|
| Lung Diseases | 2 | 2018 | 1887 | 0.560 |
Why?
|
| Genome, Human | 13 | 2019 | 4420 | 0.560 |
Why?
|
| Risk Factors | 64 | 2024 | 72296 | 0.550 |
Why?
|
| Case-Control Studies | 42 | 2022 | 21748 | 0.550 |
Why?
|
| Heart Conduction System | 2 | 2015 | 1047 | 0.550 |
Why?
|
| Polymerase Chain Reaction | 16 | 2014 | 6171 | 0.550 |
Why?
|
| Waist Circumference | 3 | 2023 | 917 | 0.540 |
Why?
|
| Environment | 4 | 2023 | 1123 | 0.540 |
Why?
|
| Adiposity | 5 | 2022 | 1806 | 0.540 |
Why?
|
| Statistics as Topic | 3 | 2021 | 2373 | 0.540 |
Why?
|
| Gene Expression Regulation | 17 | 2021 | 12073 | 0.540 |
Why?
|
| Thrombophilia | 2 | 2009 | 305 | 0.520 |
Why?
|
| Endocrine System Diseases | 2 | 2012 | 248 | 0.520 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 366 | 0.520 |
Why?
|
| Epidemiologic Studies | 3 | 2016 | 676 | 0.520 |
Why?
|
| Polymorphism, Genetic | 12 | 2019 | 4328 | 0.520 |
Why?
|
| Cognition Disorders | 5 | 2016 | 4043 | 0.510 |
Why?
|
| Urban Health | 3 | 2014 | 547 | 0.510 |
Why?
|
| Forced Expiratory Volume | 8 | 2022 | 1745 | 0.510 |
Why?
|
| Pregnancy Outcome | 12 | 2021 | 2795 | 0.500 |
Why?
|
| Canada | 9 | 2024 | 2065 | 0.500 |
Why?
|
| Mortality | 5 | 2021 | 2864 | 0.500 |
Why?
|
| Motor Vehicles | 3 | 2020 | 268 | 0.500 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2017 | 15520 | 0.500 |
Why?
|
| Genome, Mitochondrial | 5 | 2020 | 71 | 0.500 |
Why?
|
| Fertilization | 1 | 2015 | 196 | 0.500 |
Why?
|
| Child Development | 4 | 2020 | 2223 | 0.490 |
Why?
|
| Chemical Industry | 2 | 2012 | 114 | 0.490 |
Why?
|
| Spermatogenesis | 1 | 2015 | 262 | 0.490 |
Why?
|
| Tibia | 2 | 2019 | 1077 | 0.480 |
Why?
|
| Diet | 11 | 2024 | 7937 | 0.480 |
Why?
|
| Intercellular Adhesion Molecule-1 | 6 | 2014 | 1159 | 0.480 |
Why?
|
| Manganese | 5 | 2022 | 408 | 0.470 |
Why?
|
| Malondialdehyde | 1 | 2013 | 105 | 0.470 |
Why?
|
| Child, Preschool | 35 | 2023 | 41005 | 0.460 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2015 | 354 | 0.460 |
Why?
|
| Lymphocytes | 4 | 2013 | 2617 | 0.450 |
Why?
|
| Interleukin-6 | 4 | 2018 | 3203 | 0.450 |
Why?
|
| Apolipoproteins E | 3 | 2014 | 1438 | 0.450 |
Why?
|
| Telomerase | 3 | 2018 | 730 | 0.450 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2013 | 504 | 0.450 |
Why?
|
| Cell Communication | 2 | 2017 | 1621 | 0.440 |
Why?
|
| C-Reactive Protein | 8 | 2022 | 3778 | 0.440 |
Why?
|
| Bradycardia | 1 | 2015 | 307 | 0.440 |
Why?
|
| Homocysteine | 5 | 2021 | 647 | 0.440 |
Why?
|
| Blood Coagulation Disorders | 2 | 2013 | 337 | 0.440 |
Why?
|
| Micronuclei, Chromosome-Defective | 2 | 2009 | 38 | 0.430 |
Why?
|
| Coronary Disease | 4 | 2021 | 6077 | 0.430 |
Why?
|
| Air Pollution, Indoor | 4 | 2024 | 857 | 0.430 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2022 | 1988 | 0.430 |
Why?
|
| Retroelements | 2 | 2013 | 164 | 0.430 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2014 | 707 | 0.430 |
Why?
|
| Boston | 15 | 2019 | 9312 | 0.420 |
Why?
|
| Cross-Sectional Studies | 33 | 2023 | 25039 | 0.420 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 668 | 0.420 |
Why?
|
| Smoke | 1 | 2013 | 227 | 0.410 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 672 | 0.410 |
Why?
|
| Water Pollutants, Chemical | 5 | 2017 | 311 | 0.410 |
Why?
|
| DNA, Satellite | 2 | 2011 | 69 | 0.410 |
Why?
|
| Occupations | 3 | 2014 | 517 | 0.410 |
Why?
|
| Neoplasms | 17 | 2020 | 21696 | 0.410 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1607 | 0.410 |
Why?
|
| Respiratory Sounds | 2 | 2016 | 696 | 0.410 |
Why?
|
| Dust | 4 | 2024 | 482 | 0.410 |
Why?
|
| Venous Thrombosis | 3 | 2015 | 1239 | 0.410 |
Why?
|
| Flavonoids | 1 | 2015 | 443 | 0.410 |
Why?
|
| Carcinogens | 2 | 2005 | 466 | 0.400 |
Why?
|
| Occupational Health | 2 | 2016 | 808 | 0.400 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2019 | 337 | 0.400 |
Why?
|
| Vital Capacity | 6 | 2020 | 925 | 0.400 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2021 | 272 | 0.400 |
Why?
|
| Glutathione S-Transferase pi | 3 | 2018 | 97 | 0.400 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2011 | 26 | 0.390 |
Why?
|
| Adolescent | 49 | 2024 | 85779 | 0.390 |
Why?
|
| Child Abuse | 2 | 2018 | 1030 | 0.390 |
Why?
|
| Thyroid Gland | 3 | 2008 | 1173 | 0.390 |
Why?
|
| Organic Chemicals | 2 | 2009 | 211 | 0.390 |
Why?
|
| DNA Copy Number Variations | 7 | 2023 | 1941 | 0.390 |
Why?
|
| Myocardial Infarction | 7 | 2023 | 11718 | 0.390 |
Why?
|
| DNA-Binding Proteins | 6 | 2019 | 9647 | 0.380 |
Why?
|
| Methylation | 6 | 2016 | 1106 | 0.380 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2011 | 119 | 0.380 |
Why?
|
| Regression Analysis | 13 | 2021 | 6459 | 0.370 |
Why?
|
| Zinc | 2 | 2024 | 684 | 0.370 |
Why?
|
| Benzhydryl Compounds | 4 | 2019 | 845 | 0.370 |
Why?
|
| Genetic Variation | 11 | 2021 | 6542 | 0.360 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2282 | 0.350 |
Why?
|
| Inorganic Chemicals | 1 | 2009 | 10 | 0.350 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1284 | 0.350 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2017 | 91 | 0.350 |
Why?
|
| Schools | 3 | 2023 | 1433 | 0.350 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2023 | 3658 | 0.340 |
Why?
|
| Nitrogen Dioxide | 6 | 2023 | 490 | 0.340 |
Why?
|
| Mannose-Binding Lectin | 2 | 2009 | 150 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 23 | 2020 | 17446 | 0.340 |
Why?
|
| United States | 32 | 2022 | 69872 | 0.340 |
Why?
|
| Cell Nucleus | 3 | 2014 | 2969 | 0.340 |
Why?
|
| Time Factors | 24 | 2021 | 40075 | 0.330 |
Why?
|
| Mothers | 9 | 2023 | 2165 | 0.330 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2047 | 0.330 |
Why?
|
| Exosomes | 3 | 2023 | 417 | 0.330 |
Why?
|
| Accidents, Occupational | 4 | 2008 | 251 | 0.320 |
Why?
|
| Oocytes | 3 | 2020 | 1188 | 0.320 |
Why?
|
| Residence Characteristics | 1 | 2018 | 2050 | 0.320 |
Why?
|
| Infant | 27 | 2023 | 35134 | 0.320 |
Why?
|
| Poland | 6 | 2010 | 184 | 0.320 |
Why?
|
| Risk | 10 | 2019 | 9688 | 0.320 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 954 | 0.320 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2008 | 32 | 0.320 |
Why?
|
| Pilot Projects | 9 | 2024 | 8319 | 0.320 |
Why?
|
| Cross-Over Studies | 5 | 2017 | 2029 | 0.320 |
Why?
|
| Frontal Lobe | 1 | 2014 | 1406 | 0.310 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2016 | 2850 | 0.310 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2011 | 284 | 0.310 |
Why?
|
| Fibrinogen | 3 | 2014 | 894 | 0.310 |
Why?
|
| Neutrophils | 1 | 2020 | 3721 | 0.310 |
Why?
|
| Genomics | 6 | 2018 | 5717 | 0.310 |
Why?
|
| Granulosa Cells | 2 | 2019 | 121 | 0.300 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3589 | 0.300 |
Why?
|
| Blood Pressure Determination | 4 | 2019 | 633 | 0.300 |
Why?
|
| Urban Population | 7 | 2018 | 2022 | 0.300 |
Why?
|
| Lung Neoplasms | 8 | 2017 | 13104 | 0.300 |
Why?
|
| Gene Expression Profiling | 9 | 2020 | 9445 | 0.300 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2011 | 651 | 0.290 |
Why?
|
| Estrogens | 1 | 2014 | 1566 | 0.290 |
Why?
|
| Weight Gain | 7 | 2022 | 2293 | 0.290 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2022 | 3921 | 0.290 |
Why?
|
| Arsenic Poisoning | 2 | 2018 | 55 | 0.290 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2017 | 36 | 0.290 |
Why?
|
| Micronutrients | 2 | 2022 | 375 | 0.290 |
Why?
|
| Carbon Monoxide | 3 | 2019 | 531 | 0.290 |
Why?
|
| Logistic Models | 14 | 2020 | 13409 | 0.280 |
Why?
|
| Social Support | 1 | 2016 | 2118 | 0.280 |
Why?
|
| Biological Clocks | 2 | 2019 | 322 | 0.280 |
Why?
|
| Gene Expression | 6 | 2020 | 7798 | 0.280 |
Why?
|
| RNA, Viral | 1 | 2015 | 2901 | 0.280 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2021 | 1320 | 0.280 |
Why?
|
| Hematologic Neoplasms | 2 | 2017 | 1832 | 0.280 |
Why?
|
| Genes | 1 | 2010 | 1893 | 0.280 |
Why?
|
| Child Welfare | 1 | 2010 | 523 | 0.280 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2019 | 732 | 0.270 |
Why?
|
| Bone and Bones | 2 | 2023 | 2576 | 0.270 |
Why?
|
| Obesity | 17 | 2024 | 12746 | 0.270 |
Why?
|
| Nails | 5 | 2022 | 292 | 0.270 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2004 | 209 | 0.270 |
Why?
|
| Caffeine | 2 | 2022 | 699 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2006 | 245 | 0.260 |
Why?
|
| Equipment Contamination | 4 | 2008 | 185 | 0.260 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 2 | 2016 | 40 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2006 | 299 | 0.260 |
Why?
|
| Acids | 1 | 2006 | 127 | 0.260 |
Why?
|
| Spermatozoa | 2 | 2020 | 625 | 0.260 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2020 | 3047 | 0.260 |
Why?
|
| Anxiety | 6 | 2021 | 4293 | 0.260 |
Why?
|
| Health Status Indicators | 1 | 2010 | 970 | 0.250 |
Why?
|
| Sex Factors | 9 | 2020 | 10400 | 0.250 |
Why?
|
| Vulnerable Populations | 1 | 2010 | 686 | 0.250 |
Why?
|
| Saliva | 3 | 2019 | 809 | 0.250 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 535 | 0.250 |
Why?
|
| Solvents | 1 | 2006 | 302 | 0.250 |
Why?
|
| Leptin | 3 | 2023 | 1600 | 0.250 |
Why?
|
| World Health Organization | 1 | 2010 | 1318 | 0.250 |
Why?
|
| Risk Assessment | 17 | 2020 | 23336 | 0.250 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2019 | 4424 | 0.250 |
Why?
|
| Pregnant Women | 2 | 2020 | 568 | 0.250 |
Why?
|
| Genotype | 18 | 2016 | 12952 | 0.240 |
Why?
|
| Genetic Markers | 5 | 2016 | 2634 | 0.240 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3617 | 0.240 |
Why?
|
| Intubation, Intratracheal | 7 | 2008 | 1364 | 0.240 |
Why?
|
| Hazardous Substances | 2 | 2022 | 149 | 0.240 |
Why?
|
| Women's Health | 7 | 2023 | 2034 | 0.240 |
Why?
|
| Automobiles | 2 | 2016 | 116 | 0.240 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2021 | 703 | 0.240 |
Why?
|
| Age Factors | 12 | 2020 | 18373 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4554 | 0.240 |
Why?
|
| DNA Repair | 4 | 2016 | 2046 | 0.240 |
Why?
|
| Neuropsychological Tests | 6 | 2019 | 6994 | 0.240 |
Why?
|
| International Cooperation | 1 | 2010 | 1420 | 0.240 |
Why?
|
| Maximal Midexpiratory Flow Rate | 2 | 2020 | 78 | 0.230 |
Why?
|
| Mouth Mucosa | 2 | 2019 | 434 | 0.230 |
Why?
|
| Models, Genetic | 3 | 2020 | 3493 | 0.230 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2007 | 290 | 0.230 |
Why?
|
| Quantitative Trait Loci | 4 | 2021 | 2019 | 0.230 |
Why?
|
| Acne Vulgaris | 2 | 2005 | 302 | 0.230 |
Why?
|
| Cities | 4 | 2018 | 513 | 0.230 |
Why?
|
| Welding | 2 | 2014 | 89 | 0.230 |
Why?
|
| Respiratory Function Tests | 5 | 2020 | 1617 | 0.230 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2022 | 571 | 0.230 |
Why?
|
| Life Style | 6 | 2024 | 3835 | 0.230 |
Why?
|
| Morbidity | 3 | 2024 | 1768 | 0.220 |
Why?
|
| Massachusetts | 9 | 2019 | 8662 | 0.220 |
Why?
|
| Haplotypes | 5 | 2014 | 2779 | 0.220 |
Why?
|
| Myocardial Ischemia | 2 | 2010 | 2148 | 0.220 |
Why?
|
| Skin Neoplasms | 7 | 2015 | 5692 | 0.220 |
Why?
|
| Fluorocarbons | 2 | 2022 | 452 | 0.220 |
Why?
|
| Infant, Premature | 5 | 2022 | 2045 | 0.220 |
Why?
|
| Military Personnel | 1 | 2012 | 1133 | 0.220 |
Why?
|
| Immunoglobulins | 2 | 2004 | 881 | 0.220 |
Why?
|
| Thailand | 2 | 2013 | 296 | 0.210 |
Why?
|
| Acetylation | 4 | 2016 | 1084 | 0.210 |
Why?
|
| Iowa | 3 | 2016 | 101 | 0.210 |
Why?
|
| Industry | 3 | 2013 | 365 | 0.210 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.200 |
Why?
|
| Histone Code | 3 | 2017 | 163 | 0.200 |
Why?
|
| Inhibin-beta Subunits | 1 | 2001 | 25 | 0.200 |
Why?
|
| Russia | 4 | 2006 | 408 | 0.200 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2715 | 0.200 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2017 | 378 | 0.200 |
Why?
|
| Life Change Events | 2 | 2024 | 938 | 0.200 |
Why?
|
| Melanoma | 6 | 2014 | 5511 | 0.200 |
Why?
|
| Sulfur Dioxide | 2 | 2019 | 177 | 0.200 |
Why?
|
| Glutathione Transferase | 5 | 2011 | 595 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1115 | 0.200 |
Why?
|
| Cadmium | 3 | 2022 | 212 | 0.200 |
Why?
|
| Pituitary Gland | 2 | 2001 | 665 | 0.200 |
Why?
|
| Ventilators, Mechanical | 4 | 2008 | 292 | 0.200 |
Why?
|
| Disinfectants | 3 | 2008 | 116 | 0.200 |
Why?
|
| Multivariate Analysis | 9 | 2017 | 12244 | 0.200 |
Why?
|
| Rats, Wistar | 5 | 2018 | 1892 | 0.200 |
Why?
|
| Alkanesulfonic Acids | 2 | 2022 | 180 | 0.200 |
Why?
|
| Cadherins | 3 | 2016 | 907 | 0.200 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2017 | 489 | 0.200 |
Why?
|
| North Carolina | 3 | 2016 | 315 | 0.200 |
Why?
|
| Cold Temperature | 2 | 2016 | 772 | 0.190 |
Why?
|
| Bangladesh | 7 | 2017 | 687 | 0.190 |
Why?
|
| Aging, Premature | 1 | 2021 | 47 | 0.190 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 468 | 0.190 |
Why?
|
| Prognosis | 13 | 2020 | 29060 | 0.190 |
Why?
|
| Translocation, Genetic | 2 | 2006 | 1420 | 0.190 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1888 | 0.190 |
Why?
|
| Genomic Imprinting | 2 | 2021 | 328 | 0.190 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 1707 | 0.190 |
Why?
|
| Incidence | 13 | 2023 | 20952 | 0.190 |
Why?
|
| Alcoholism | 1 | 2011 | 1906 | 0.180 |
Why?
|
| Animals | 27 | 2022 | 168768 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 4 | 2021 | 2166 | 0.180 |
Why?
|
| Cause of Death | 3 | 2020 | 3582 | 0.180 |
Why?
|
| Activins | 1 | 2001 | 208 | 0.180 |
Why?
|
| Follow-Up Studies | 13 | 2021 | 39052 | 0.180 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 3966 | 0.180 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2760 | 0.180 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 4 | 2005 | 257 | 0.180 |
Why?
|
| Postpartum Period | 3 | 2022 | 1086 | 0.180 |
Why?
|
| Antioxidants | 3 | 2021 | 1659 | 0.180 |
Why?
|
| Body Burden | 2 | 2014 | 158 | 0.180 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2008 | 274 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 689 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1596 | 0.170 |
Why?
|
| 5-Methylcytosine | 3 | 2015 | 154 | 0.170 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2021 | 245 | 0.170 |
Why?
|
| Seasons | 3 | 2017 | 1493 | 0.170 |
Why?
|
| Endocrine Glands | 1 | 1999 | 103 | 0.170 |
Why?
|
| United States Environmental Protection Agency | 2 | 2017 | 139 | 0.170 |
Why?
|
| Atherosclerosis | 4 | 2021 | 3444 | 0.170 |
Why?
|
| Parabens | 1 | 2020 | 108 | 0.170 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 12356 | 0.170 |
Why?
|
| Ovarian Follicle | 1 | 2021 | 248 | 0.170 |
Why?
|
| Earthquakes | 1 | 2021 | 179 | 0.170 |
Why?
|
| Phenotype | 13 | 2021 | 16367 | 0.170 |
Why?
|
| Fertility | 3 | 2020 | 781 | 0.170 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2024 | 373 | 0.170 |
Why?
|
| Prothrombin Time | 2 | 2009 | 119 | 0.170 |
Why?
|
| Algorithms | 5 | 2019 | 13882 | 0.170 |
Why?
|
| Single-Blind Method | 3 | 2017 | 1590 | 0.160 |
Why?
|
| Language Tests | 1 | 2019 | 202 | 0.160 |
Why?
|
| Base Sequence | 7 | 2013 | 12797 | 0.160 |
Why?
|
| Denmark | 1 | 2021 | 738 | 0.160 |
Why?
|
| Wechsler Scales | 1 | 2019 | 260 | 0.160 |
Why?
|
| Endothelium, Vascular | 4 | 2019 | 4459 | 0.160 |
Why?
|
| Tobacco, Smokeless | 1 | 2019 | 130 | 0.160 |
Why?
|
| Population Groups | 1 | 2019 | 209 | 0.160 |
Why?
|
| Overweight | 3 | 2020 | 2371 | 0.160 |
Why?
|
| Interpersonal Relations | 2 | 2016 | 1425 | 0.160 |
Why?
|
| Alleles | 4 | 2019 | 6933 | 0.160 |
Why?
|
| Benzene Derivatives | 1 | 2017 | 54 | 0.160 |
Why?
|
| Exercise | 3 | 2019 | 5615 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.160 |
Why?
|
| Ribonuclease III | 2 | 2018 | 275 | 0.160 |
Why?
|
| Veterans Health | 2 | 2016 | 216 | 0.160 |
Why?
|
| Intelligence Tests | 1 | 2019 | 505 | 0.150 |
Why?
|
| Immunoglobulin E | 3 | 2019 | 1463 | 0.150 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2020 | 183 | 0.150 |
Why?
|
| Antibody Formation | 1 | 2002 | 1402 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2019 | 10943 | 0.150 |
Why?
|
| Testis | 1 | 2001 | 804 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2019 | 440 | 0.150 |
Why?
|
| Patella | 1 | 2019 | 320 | 0.150 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2018 | 81 | 0.150 |
Why?
|
| Lung Injury | 1 | 2023 | 436 | 0.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2017 | 985 | 0.150 |
Why?
|
| Stroke | 4 | 2023 | 9981 | 0.150 |
Why?
|
| Skin Physiological Phenomena | 1 | 2018 | 180 | 0.150 |
Why?
|
| Pest Control | 1 | 2017 | 30 | 0.150 |
Why?
|
| Kidney | 4 | 2021 | 7184 | 0.150 |
Why?
|
| Body Weights and Measures | 2 | 2017 | 211 | 0.150 |
Why?
|
| Agriculture | 2 | 2022 | 186 | 0.150 |
Why?
|
| Insulin Resistance | 4 | 2023 | 3864 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 3 | 2016 | 2716 | 0.150 |
Why?
|
| Spirituality | 1 | 2021 | 405 | 0.150 |
Why?
|
| Space-Time Clustering | 1 | 2016 | 49 | 0.150 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 63 | 0.150 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2018 | 159 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2018 | 369 | 0.150 |
Why?
|
| Disease Susceptibility | 2 | 2017 | 1782 | 0.150 |
Why?
|
| Sulfathiazoles | 1 | 2016 | 3 | 0.140 |
Why?
|
| Obesity, Abdominal | 1 | 2020 | 361 | 0.140 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2016 | 54 | 0.140 |
Why?
|
| Ovary | 1 | 2001 | 981 | 0.140 |
Why?
|
| Models, Statistical | 4 | 2017 | 5101 | 0.140 |
Why?
|
| Live Birth | 1 | 2020 | 512 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2020 | 379 | 0.140 |
Why?
|
| New England | 2 | 2016 | 1022 | 0.140 |
Why?
|
| Body Height | 3 | 2018 | 1578 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2024 | 849 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 115 | 0.140 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2018 | 303 | 0.140 |
Why?
|
| Nervous System | 1 | 2020 | 554 | 0.140 |
Why?
|
| Chemokine CXCL12 | 2 | 2009 | 465 | 0.140 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2015 | 16 | 0.140 |
Why?
|
| Nanotubes, Carbon | 1 | 2017 | 73 | 0.140 |
Why?
|
| Progeria | 1 | 2018 | 185 | 0.140 |
Why?
|
| Wnt2 Protein | 1 | 2015 | 28 | 0.140 |
Why?
|
| Blood Cells | 1 | 2018 | 309 | 0.140 |
Why?
|
| Time | 2 | 2016 | 542 | 0.140 |
Why?
|
| Carbonated Beverages | 1 | 2017 | 214 | 0.140 |
Why?
|
| Repressor Proteins | 3 | 2017 | 3024 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2017 | 271 | 0.140 |
Why?
|
| DNA Modification Methylases | 1 | 2016 | 206 | 0.140 |
Why?
|
| Endothelin-1 | 2 | 2019 | 314 | 0.140 |
Why?
|
| Marriage | 1 | 2017 | 339 | 0.140 |
Why?
|
| Fasting | 2 | 2016 | 1592 | 0.140 |
Why?
|
| Reproduction | 1 | 2021 | 668 | 0.140 |
Why?
|
| Satellite Communications | 1 | 2015 | 13 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 3524 | 0.130 |
Why?
|
| Meningomyelocele | 1 | 2017 | 165 | 0.130 |
Why?
|
| Toluene | 1 | 2015 | 32 | 0.130 |
Why?
|
| Narcotics | 1 | 2018 | 343 | 0.130 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 365 | 0.130 |
Why?
|
| Depression | 4 | 2020 | 7759 | 0.130 |
Why?
|
| Health Behavior | 3 | 2024 | 2635 | 0.130 |
Why?
|
| Uric Acid | 1 | 2021 | 766 | 0.130 |
Why?
|
| Vaginosis, Bacterial | 1 | 2016 | 128 | 0.130 |
Why?
|
| RNA-Binding Proteins | 4 | 2018 | 1903 | 0.130 |
Why?
|
| Anthropometry | 2 | 2018 | 1350 | 0.130 |
Why?
|
| Health Education | 1 | 2022 | 1056 | 0.130 |
Why?
|
| Adenosine | 1 | 2020 | 825 | 0.130 |
Why?
|
| Adenocarcinoma | 2 | 2010 | 6364 | 0.130 |
Why?
|
| Pregnancy Complications | 3 | 2020 | 2861 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 804 | 0.130 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 192 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2019 | 711 | 0.130 |
Why?
|
| RNA | 3 | 2023 | 2749 | 0.130 |
Why?
|
| Hair Color | 2 | 2006 | 136 | 0.130 |
Why?
|
| Carcinogens, Environmental | 1 | 2015 | 67 | 0.130 |
Why?
|
| Hostility | 1 | 2016 | 189 | 0.130 |
Why?
|
| Computational Biology | 4 | 2015 | 3519 | 0.130 |
Why?
|
| Umbilical Arteries | 1 | 2015 | 75 | 0.130 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2014 | 54 | 0.130 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 349 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2018 | 690 | 0.120 |
Why?
|
| Transcription Factors | 5 | 2019 | 12207 | 0.120 |
Why?
|
| Optical Phenomena | 1 | 2015 | 107 | 0.120 |
Why?
|
| Thyroid Hormones | 1 | 2017 | 390 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2017 | 3143 | 0.120 |
Why?
|
| Skin Diseases | 2 | 2014 | 1066 | 0.120 |
Why?
|
| Noise | 1 | 2016 | 279 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2012 | 705 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 780 | 0.120 |
Why?
|
| Diabetes Mellitus | 4 | 2020 | 5749 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2015 | 123 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2011 | 65 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 240 | 0.120 |
Why?
|
| Body Weight | 4 | 2018 | 4671 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 4266 | 0.120 |
Why?
|
| DNA Transposable Elements | 2 | 2015 | 748 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 19905 | 0.120 |
Why?
|
| Alcohol-Related Disorders | 1 | 2016 | 234 | 0.120 |
Why?
|
| Poisoning | 1 | 2015 | 249 | 0.120 |
Why?
|
| Health Status | 2 | 2021 | 4034 | 0.120 |
Why?
|
| Growth and Development | 1 | 2014 | 52 | 0.120 |
Why?
|
| Silicon | 1 | 2014 | 145 | 0.120 |
Why?
|
| Silver Sulfadiazine | 3 | 2008 | 8 | 0.120 |
Why?
|
| Aluminum | 1 | 2014 | 152 | 0.120 |
Why?
|
| Antigens, CD | 3 | 2016 | 4026 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2023 | 11726 | 0.120 |
Why?
|
| Obstetric Labor, Premature | 1 | 2015 | 279 | 0.120 |
Why?
|
| Maternal Age | 3 | 2022 | 802 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2019 | 1124 | 0.120 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2016 | 245 | 0.120 |
Why?
|
| RNA, Ribosomal | 1 | 2015 | 245 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2021 | 23404 | 0.120 |
Why?
|
| School Health Services | 1 | 2017 | 375 | 0.120 |
Why?
|
| Intelligence | 1 | 2019 | 920 | 0.120 |
Why?
|
| Lymphoma | 1 | 2002 | 1877 | 0.110 |
Why?
|
| Umbilical Cord | 1 | 2015 | 180 | 0.110 |
Why?
|
| Triglycerides | 4 | 2023 | 2453 | 0.110 |
Why?
|
| Morphine | 1 | 2018 | 657 | 0.110 |
Why?
|
| Semen | 1 | 2015 | 316 | 0.110 |
Why?
|
| Bulgaria | 1 | 2012 | 25 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2021 | 2016 | 0.110 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2014 | 188 | 0.110 |
Why?
|
| Odds Ratio | 6 | 2017 | 9849 | 0.110 |
Why?
|
| Androgens | 1 | 2020 | 1281 | 0.110 |
Why?
|
| Leiomyoma | 1 | 2018 | 730 | 0.110 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 1270 | 0.110 |
Why?
|
| Diazinon | 1 | 2012 | 4 | 0.110 |
Why?
|
| Biometry | 1 | 2016 | 558 | 0.110 |
Why?
|
| Gold | 1 | 2017 | 484 | 0.110 |
Why?
|
| Spain | 1 | 2014 | 465 | 0.110 |
Why?
|
| Dinoprostone | 1 | 2016 | 601 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 1213 | 0.110 |
Why?
|
| Coffee | 1 | 2017 | 578 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 431 | 0.110 |
Why?
|
| Geography | 1 | 2015 | 669 | 0.110 |
Why?
|
| Smoking Cessation | 3 | 2016 | 2071 | 0.110 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2012 | 25 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 201 | 0.110 |
Why?
|
| Endotoxins | 1 | 2015 | 527 | 0.110 |
Why?
|
| Aerosols | 1 | 2015 | 625 | 0.110 |
Why?
|
| Europe | 1 | 2019 | 3338 | 0.110 |
Why?
|
| Receptors, CXCR4 | 2 | 2009 | 727 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2012 | 361 | 0.110 |
Why?
|
| Publications | 1 | 2015 | 195 | 0.110 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2016 | 182 | 0.110 |
Why?
|
| Psoriasis | 1 | 2020 | 902 | 0.110 |
Why?
|
| Statistics, Nonparametric | 3 | 2014 | 2887 | 0.110 |
Why?
|
| Kidney Calculi | 2 | 2008 | 465 | 0.110 |
Why?
|
| Blood | 1 | 2015 | 598 | 0.110 |
Why?
|
| Food | 1 | 2017 | 772 | 0.110 |
Why?
|
| Leadership | 1 | 2022 | 1357 | 0.110 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 405 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2019 | 904 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 4 | 2019 | 875 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 257 | 0.100 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 367 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 168 | 0.100 |
Why?
|
| Base Composition | 1 | 2012 | 293 | 0.100 |
Why?
|
| Cytokines | 2 | 2017 | 7323 | 0.100 |
Why?
|
| Psychological Tests | 2 | 2012 | 651 | 0.100 |
Why?
|
| Government Regulation | 1 | 2016 | 522 | 0.100 |
Why?
|
| Forecasting | 2 | 2015 | 2951 | 0.100 |
Why?
|
| Quality of Life | 3 | 2024 | 12802 | 0.100 |
Why?
|
| Postmenopause | 1 | 2021 | 2460 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 622 | 0.100 |
Why?
|
| Fibroblasts | 3 | 2018 | 4162 | 0.100 |
Why?
|
| Glucose | 2 | 2023 | 4398 | 0.100 |
Why?
|
| Oxygen | 1 | 2023 | 4189 | 0.100 |
Why?
|
| Titanium | 1 | 2014 | 494 | 0.100 |
Why?
|
| Pituitary-Adrenal System | 3 | 2021 | 553 | 0.100 |
Why?
|
| Acceleration | 2 | 2023 | 181 | 0.100 |
Why?
|
| Radiation, Ionizing | 1 | 2012 | 258 | 0.100 |
Why?
|
| Hydrocortisone | 2 | 2018 | 1826 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2023 | 2949 | 0.100 |
Why?
|
| Protective Agents | 1 | 2012 | 156 | 0.100 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2585 | 0.100 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2012 | 188 | 0.100 |
Why?
|
| Proteins | 3 | 2014 | 6100 | 0.100 |
Why?
|
| Bacteria | 1 | 2022 | 2115 | 0.100 |
Why?
|
| Agricultural Workers' Diseases | 2 | 2015 | 29 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1790 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 643 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 427 | 0.100 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2011 | 67 | 0.100 |
Why?
|
| False Positive Reactions | 1 | 2013 | 980 | 0.100 |
Why?
|
| Dyspnea | 2 | 2016 | 1303 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 675 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2009 | 1837 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2015 | 541 | 0.100 |
Why?
|
| Allergens | 2 | 2021 | 1320 | 0.100 |
Why?
|
| Insecticides | 1 | 2012 | 195 | 0.090 |
Why?
|
| Genetic Research | 1 | 2011 | 174 | 0.090 |
Why?
|
| Nasal Polyps | 1 | 2016 | 360 | 0.090 |
Why?
|
| Infertility | 1 | 2017 | 655 | 0.090 |
Why?
|
| Inhalation | 1 | 2010 | 143 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 1572 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2015 | 694 | 0.090 |
Why?
|
| Mutation | 5 | 2021 | 29786 | 0.090 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2010 | 81 | 0.090 |
Why?
|
| Pyrenes | 1 | 2009 | 46 | 0.090 |
Why?
|
| Personality | 1 | 2014 | 552 | 0.090 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 2009 | 41 | 0.090 |
Why?
|
| Centromere | 1 | 2011 | 220 | 0.090 |
Why?
|
| Adenoma | 3 | 2008 | 2174 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 8038 | 0.090 |
Why?
|
| Glucocorticoids | 3 | 2012 | 2108 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2019 | 2148 | 0.090 |
Why?
|
| Population Surveillance | 3 | 2008 | 2616 | 0.090 |
Why?
|
| Deoxyguanosine | 1 | 2010 | 84 | 0.090 |
Why?
|
| Life Expectancy | 1 | 2016 | 1184 | 0.090 |
Why?
|
| Ovulation Induction | 2 | 2023 | 274 | 0.090 |
Why?
|
| Confidence Intervals | 2 | 2013 | 2971 | 0.090 |
Why?
|
| Quebec | 2 | 2020 | 134 | 0.090 |
Why?
|
| Lipoprotein Lipase | 1 | 2010 | 126 | 0.090 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2010 | 144 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2021 | 1905 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.090 |
Why?
|
| Anemia | 1 | 2019 | 1503 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 2 | 2020 | 1602 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2005 | 1213 | 0.090 |
Why?
|
| Helicobacter pylori | 2 | 2009 | 383 | 0.090 |
Why?
|
| Sunlight | 4 | 2004 | 325 | 0.080 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2009 | 48 | 0.080 |
Why?
|
| Helicobacter Infections | 2 | 2009 | 387 | 0.080 |
Why?
|
| Arsenicals | 1 | 2009 | 124 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 2009 | 206 | 0.080 |
Why?
|
| Survival Rate | 4 | 2017 | 12788 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1312 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1783 | 0.080 |
Why?
|
| Transforming Growth Factors | 1 | 2008 | 76 | 0.080 |
Why?
|
| Kidney Function Tests | 2 | 2021 | 683 | 0.080 |
Why?
|
| Spirometry | 3 | 2020 | 865 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 974 | 0.080 |
Why?
|
| Dementia | 1 | 2023 | 2518 | 0.080 |
Why?
|
| Meteorological Concepts | 1 | 2008 | 30 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2020 | 1947 | 0.080 |
Why?
|
| Heme Oxygenase-1 | 2 | 2008 | 381 | 0.080 |
Why?
|
| Glutathione | 1 | 2011 | 590 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2001 | 744 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18111 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2019 | 14723 | 0.080 |
Why?
|
| Self Report | 1 | 2019 | 3553 | 0.080 |
Why?
|
| Sequence Analysis | 1 | 2008 | 256 | 0.080 |
Why?
|
| Sulfites | 3 | 2015 | 78 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2011 | 659 | 0.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 436 | 0.080 |
Why?
|
| Luteinizing Hormone | 2 | 2001 | 869 | 0.080 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 4262 | 0.080 |
Why?
|
| Tissue Array Analysis | 2 | 2009 | 553 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2419 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2017 | 2455 | 0.080 |
Why?
|
| Oocyte Retrieval | 2 | 2020 | 161 | 0.080 |
Why?
|
| Hypersensitivity | 2 | 2016 | 1102 | 0.080 |
Why?
|
| Cyclooxygenase 1 | 1 | 2007 | 104 | 0.080 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 906 | 0.080 |
Why?
|
| Thyroid Function Tests | 1 | 2008 | 286 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2014 | 1904 | 0.080 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2009 | 426 | 0.080 |
Why?
|
| Heart | 1 | 2021 | 4464 | 0.080 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2004 | 38 | 0.070 |
Why?
|
| Income | 1 | 2016 | 1913 | 0.070 |
Why?
|
| Patient Admission | 1 | 2015 | 1380 | 0.070 |
Why?
|
| Calcium | 3 | 2014 | 5755 | 0.070 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 1372 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2016 | 2132 | 0.070 |
Why?
|
| Israel | 2 | 2021 | 796 | 0.070 |
Why?
|
| Thrombin | 1 | 2009 | 598 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2009 | 755 | 0.070 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2006 | 20 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2838 | 0.070 |
Why?
|
| Cholesterol, HDL | 2 | 2024 | 1813 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 1097 | 0.070 |
Why?
|
| Choline | 2 | 2022 | 493 | 0.070 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 3508 | 0.070 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2008 | 160 | 0.070 |
Why?
|
| Maximum Allowable Concentration | 1 | 2006 | 62 | 0.070 |
Why?
|
| Respiratory Tract Infections | 2 | 2004 | 961 | 0.070 |
Why?
|
| Colony Count, Microbial | 4 | 2008 | 331 | 0.070 |
Why?
|
| Receptors, Interferon | 1 | 2006 | 115 | 0.070 |
Why?
|
| Poisson Distribution | 2 | 2019 | 513 | 0.070 |
Why?
|
| Pituitary Neoplasms | 2 | 2008 | 1345 | 0.070 |
Why?
|
| Germany | 2 | 2020 | 862 | 0.070 |
Why?
|
| Gases | 1 | 2006 | 197 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 563 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2014 | 2499 | 0.070 |
Why?
|
| Testosterone | 3 | 2020 | 2419 | 0.070 |
Why?
|
| Blood Coagulation Tests | 1 | 2006 | 263 | 0.070 |
Why?
|
| Contraceptives, Oral | 1 | 2008 | 564 | 0.070 |
Why?
|
| Methionine | 1 | 2008 | 590 | 0.070 |
Why?
|
| RNA, Messenger | 6 | 2016 | 13035 | 0.070 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2005 | 46 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 214 | 0.060 |
Why?
|
| HIV Infections | 2 | 2021 | 16715 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2016 | 2026 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 612 | 0.060 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2005 | 49 | 0.060 |
Why?
|
| Th1 Cells | 2 | 2008 | 1057 | 0.060 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 453 | 0.060 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 20824 | 0.060 |
Why?
|
| Vitamins | 2 | 2024 | 1623 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2018 | 5023 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2076 | 0.060 |
Why?
|
| Cells, Cultured | 6 | 2019 | 19233 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4463 | 0.060 |
Why?
|
| Food Industry | 1 | 2005 | 68 | 0.060 |
Why?
|
| Neoplasm Proteins | 3 | 2012 | 3707 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 977 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 1939 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2005 | 160 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2005 | 183 | 0.060 |
Why?
|
| Fruit | 1 | 2009 | 1142 | 0.060 |
Why?
|
| Cell Line | 4 | 2016 | 16000 | 0.060 |
Why?
|
| Vegetables | 1 | 2009 | 1182 | 0.060 |
Why?
|
| Population | 1 | 2004 | 142 | 0.060 |
Why?
|
| Genetic Association Studies | 4 | 2016 | 2703 | 0.060 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2004 | 105 | 0.060 |
Why?
|
| Interleukins | 1 | 2008 | 791 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 2004 | 145 | 0.060 |
Why?
|
| Somatostatin | 1 | 2005 | 459 | 0.060 |
Why?
|
| Administrative Personnel | 1 | 2005 | 187 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2017 | 6442 | 0.060 |
Why?
|
| Complement C4 | 1 | 2004 | 257 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1161 | 0.060 |
Why?
|
| Hyperparathyroidism | 1 | 2005 | 339 | 0.060 |
Why?
|
| Suction | 1 | 2004 | 267 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2008 | 658 | 0.060 |
Why?
|
| Fluorides | 1 | 2023 | 127 | 0.060 |
Why?
|
| Dominican Republic | 1 | 2023 | 76 | 0.060 |
Why?
|
| Coal | 1 | 2023 | 119 | 0.060 |
Why?
|
| Arteries | 2 | 2021 | 1119 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5974 | 0.060 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2009 | 1261 | 0.060 |
Why?
|
| Skin Tests | 2 | 2017 | 613 | 0.060 |
Why?
|
| Sheep | 4 | 2008 | 1437 | 0.060 |
Why?
|
| Prevalence | 6 | 2018 | 15221 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3690 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2008 | 1031 | 0.050 |
Why?
|
| Brain | 3 | 2023 | 26388 | 0.050 |
Why?
|
| Acromegaly | 1 | 2005 | 347 | 0.050 |
Why?
|
| Educational Status | 2 | 2024 | 2540 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 6773 | 0.050 |
Why?
|
| Sleep | 1 | 2018 | 4622 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2022 | 6486 | 0.050 |
Why?
|
| Mozambique | 1 | 2022 | 54 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2008 | 745 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2011 | 8436 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2016 | 6194 | 0.050 |
Why?
|
| Adult Children | 1 | 2023 | 100 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2375 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2018 | 967 | 0.050 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 2014 | 72 | 0.050 |
Why?
|
| Rural Population | 1 | 2012 | 2207 | 0.050 |
Why?
|
| Complement C3 | 1 | 2004 | 461 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Retrospective Studies | 7 | 2023 | 77460 | 0.050 |
Why?
|
| Accidents | 1 | 2002 | 164 | 0.050 |
Why?
|
| Research Design | 2 | 2017 | 5984 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1340 | 0.050 |
Why?
|
| DNA Primers | 3 | 2015 | 2891 | 0.050 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 2 | 2011 | 56 | 0.050 |
Why?
|
| tau Proteins | 1 | 2011 | 1868 | 0.050 |
Why?
|
| Half-Life | 1 | 2022 | 661 | 0.050 |
Why?
|
| Breast Feeding | 2 | 2023 | 1338 | 0.050 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2014 | 298 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2016 | 10252 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3079 | 0.050 |
Why?
|
| Dietary Supplements | 3 | 2021 | 3296 | 0.050 |
Why?
|
| Demography | 2 | 2017 | 1655 | 0.050 |
Why?
|
| Inhibins | 1 | 2001 | 211 | 0.050 |
Why?
|
| Teratogens | 1 | 2001 | 112 | 0.050 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 249 | 0.050 |
Why?
|
| Plants | 1 | 2022 | 316 | 0.050 |
Why?
|
| Impulsive Behavior | 1 | 2023 | 316 | 0.050 |
Why?
|
| Chorionic Gonadotropin | 1 | 2023 | 476 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2009 | 1253 | 0.050 |
Why?
|
| K562 Cells | 2 | 2012 | 635 | 0.050 |
Why?
|
| Puberty | 1 | 2024 | 490 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 2147 | 0.050 |
Why?
|
| Sunburn | 1 | 2001 | 155 | 0.050 |
Why?
|
| Chromatin | 1 | 2012 | 2933 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4839 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1178 | 0.050 |
Why?
|
| Twins, Dizygotic | 1 | 2020 | 236 | 0.050 |
Why?
|
| Cholesterol | 2 | 2019 | 2919 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2015 | 3309 | 0.050 |
Why?
|
| Vietnam Conflict | 1 | 2020 | 99 | 0.050 |
Why?
|
| Basal Ganglia | 1 | 2023 | 546 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 596 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3010 | 0.040 |
Why?
|
| Pineal Gland | 1 | 2000 | 166 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3771 | 0.040 |
Why?
|
| Research | 2 | 2005 | 1999 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
| Skin Pigmentation | 1 | 2001 | 282 | 0.040 |
Why?
|
| Lipids | 2 | 2021 | 3307 | 0.040 |
Why?
|
| Nigeria | 1 | 2022 | 733 | 0.040 |
Why?
|
| North America | 1 | 2023 | 1249 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4034 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12025 | 0.040 |
Why?
|
| Cortisone | 1 | 2019 | 89 | 0.040 |
Why?
|
| Reference Values | 2 | 2024 | 4982 | 0.040 |
Why?
|
| Thrombosis | 1 | 2013 | 2968 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 2134 | 0.040 |
Why?
|
| Parturition | 1 | 2022 | 441 | 0.040 |
Why?
|
| Dicarboxylic Acids | 1 | 2018 | 69 | 0.040 |
Why?
|
| Parathyroid Glands | 1 | 2000 | 509 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2005 | 975 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3511 | 0.040 |
Why?
|
| Fetal Macrosomia | 1 | 2019 | 124 | 0.040 |
Why?
|
| Hemoglobins | 2 | 2020 | 1532 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 767 | 0.040 |
Why?
|
| Vocabulary | 1 | 2019 | 169 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2004 | 861 | 0.040 |
Why?
|
| Adipokines | 1 | 2020 | 320 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 252 | 0.040 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 948 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2019 | 237 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2000 | 546 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2020 | 548 | 0.040 |
Why?
|
| Rats | 4 | 2018 | 24252 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2916 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 3611 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2011 | 3587 | 0.040 |
Why?
|
| Mother-Child Relations | 1 | 2021 | 481 | 0.040 |
Why?
|
| Ghana | 1 | 2018 | 284 | 0.040 |
Why?
|
| Polyurethanes | 2 | 2008 | 107 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 1060 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 4666 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 944 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.040 |
Why?
|
| Protein Modification, Translational | 1 | 2016 | 21 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 1151 | 0.040 |
Why?
|
| Disasters | 1 | 2003 | 511 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4851 | 0.040 |
Why?
|
| Cosmetics | 1 | 2018 | 97 | 0.040 |
Why?
|
| Ferritins | 1 | 2020 | 590 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2002 | 740 | 0.040 |
Why?
|
| Habits | 1 | 2017 | 139 | 0.040 |
Why?
|
| Fibrosis | 1 | 2024 | 2029 | 0.040 |
Why?
|
| South Africa | 1 | 2022 | 1731 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 8432 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3280 | 0.040 |
Why?
|
| Genetic Loci | 2 | 2020 | 2575 | 0.040 |
Why?
|
| Feces | 1 | 2023 | 1401 | 0.040 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 20 | 0.040 |
Why?
|
| Environmental Pollution | 1 | 2018 | 118 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2023 | 1005 | 0.040 |
Why?
|
| Oxalates | 2 | 2008 | 105 | 0.040 |
Why?
|
| Potassium | 1 | 2021 | 1336 | 0.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2023 | 1206 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 87 | 0.030 |
Why?
|
| Netherlands | 1 | 2021 | 2170 | 0.030 |
Why?
|
| American Heart Association | 1 | 2021 | 1057 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2018 | 2624 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15535 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2019 | 811 | 0.030 |
Why?
|
| Suburban Population | 1 | 2015 | 55 | 0.030 |
Why?
|
| Virginia | 1 | 2016 | 121 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2008 | 963 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2019 | 493 | 0.030 |
Why?
|
| Malathion | 1 | 2015 | 6 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10259 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2008 | 319 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2021 | 934 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2004 | 1401 | 0.030 |
Why?
|
| Trachea | 2 | 2017 | 1076 | 0.030 |
Why?
|
| Parity | 1 | 2019 | 929 | 0.030 |
Why?
|
| Education | 1 | 2019 | 543 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4751 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2004 | 2569 | 0.030 |
Why?
|
| Sodium | 1 | 2021 | 1622 | 0.030 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2015 | 7 | 0.030 |
Why?
|
| Creatinine | 1 | 2021 | 1919 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2018 | 723 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2012 | 2204 | 0.030 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 137 | 0.030 |
Why?
|
| Menarche | 1 | 2018 | 516 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7785 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2000 | 1063 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 270 | 0.030 |
Why?
|
| Chlorhexidine | 2 | 2008 | 162 | 0.030 |
Why?
|
| Progesterone | 1 | 2019 | 775 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1184 | 0.030 |
Why?
|
| Weather | 1 | 2015 | 228 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2021 | 1236 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2017 | 643 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1809 | 0.030 |
Why?
|
| Blastocyst | 1 | 2017 | 424 | 0.030 |
Why?
|
| Maze Learning | 1 | 2016 | 478 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 2002 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 2355 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11126 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
| HIV | 1 | 2021 | 1604 | 0.030 |
Why?
|
| Tryptophan | 1 | 2016 | 478 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1655 | 0.030 |
Why?
|
| E-Selectin | 1 | 2016 | 579 | 0.030 |
Why?
|
| Walking | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Health Occupations | 1 | 2015 | 224 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 2428 | 0.030 |
Why?
|
| DDT | 1 | 2013 | 31 | 0.030 |
Why?
|
| Acetamides | 1 | 2015 | 249 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 3 | 2009 | 3616 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2014 | 3207 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2439 | 0.030 |
Why?
|
| Immunity | 1 | 2019 | 1014 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 18034 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2022 | 2073 | 0.030 |
Why?
|
| Adiponectin | 1 | 2019 | 1101 | 0.030 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2013 | 52 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 850 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 1 | 2012 | 227 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2015 | 340 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 604 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2012 | 96 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 894 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 898 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3300 | 0.030 |
Why?
|
| Sarcosine Dehydrogenase | 1 | 2011 | 5 | 0.030 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 2011 | 5 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5181 | 0.030 |
Why?
|
| Attention | 1 | 2023 | 2397 | 0.030 |
Why?
|
| Aminohydrolases | 1 | 2011 | 18 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15078 | 0.030 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 17 | 0.030 |
Why?
|
| Caprylates | 1 | 2012 | 111 | 0.030 |
Why?
|
| Mathematical Computing | 1 | 2012 | 147 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 1007 | 0.030 |
Why?
|
| Oman | 1 | 2011 | 18 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2015 | 837 | 0.030 |
Why?
|
| Thromboplastin | 1 | 2014 | 291 | 0.030 |
Why?
|
| Betaine | 1 | 2012 | 87 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 1216 | 0.030 |
Why?
|
| Health Services | 1 | 2017 | 758 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2013 | 356 | 0.030 |
Why?
|
| Receptors, Thrombin | 1 | 2012 | 131 | 0.030 |
Why?
|
| Estradiol | 1 | 2019 | 2020 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 2902 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2013 | 275 | 0.020 |
Why?
|
| Fetus | 1 | 2019 | 1880 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13693 | 0.020 |
Why?
|
| Haplorhini | 1 | 2012 | 552 | 0.020 |
Why?
|
| Biofilms | 2 | 2008 | 617 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 5181 | 0.020 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2011 | 163 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 2016 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2184 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2020 | 1373 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2016 | 478 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 587 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2012 | 272 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2726 | 0.020 |
Why?
|
| Software | 2 | 2015 | 4441 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2012 | 314 | 0.020 |
Why?
|
| alpha-Synuclein | 1 | 2016 | 722 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 789 | 0.020 |
Why?
|
| Psychology | 1 | 2012 | 356 | 0.020 |
Why?
|
| Cleft Palate | 1 | 2016 | 560 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2016 | 722 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1485 | 0.020 |
Why?
|
| Ethanol | 1 | 2016 | 1342 | 0.020 |
Why?
|
| Atrial Appendage | 1 | 2014 | 283 | 0.020 |
Why?
|
| Models, Biological | 3 | 2011 | 9584 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 3390 | 0.020 |
Why?
|
| Menopause | 1 | 2018 | 1626 | 0.020 |
Why?
|
| Arabs | 1 | 2011 | 178 | 0.020 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1344 | 0.020 |
Why?
|
| Receptors, CXCR | 1 | 2009 | 52 | 0.020 |
Why?
|
| Eating | 1 | 2016 | 1536 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3954 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 940 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2009 | 84 | 0.020 |
Why?
|
| Greenland | 1 | 2008 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2009 | 141 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3595 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2023 | 9145 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 783 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 2967 | 0.020 |
Why?
|
| Soil Pollutants | 1 | 2008 | 71 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Skin | 1 | 2002 | 4372 | 0.020 |
Why?
|
| Liver | 1 | 2024 | 7475 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2011 | 686 | 0.020 |
Why?
|
| Systems Biology | 1 | 2011 | 469 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2008 | 288 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7182 | 0.020 |
Why?
|
| Comorbidity | 2 | 2012 | 10388 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6386 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2012 | 775 | 0.020 |
Why?
|
| Silver | 1 | 2008 | 122 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 4740 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6366 | 0.020 |
Why?
|
| Acneiform Eruptions | 1 | 2006 | 4 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2010 | 641 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 375 | 0.020 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2007 | 80 | 0.020 |
Why?
|
| Endothelium | 1 | 2010 | 778 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2890 | 0.020 |
Why?
|
| Platinum | 1 | 2008 | 233 | 0.020 |
Why?
|
| Mice | 3 | 2022 | 81201 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2007 | 378 | 0.020 |
Why?
|
| Rhinitis | 1 | 2014 | 691 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 3001 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9724 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1061 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 692 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10483 | 0.020 |
Why?
|
| Chlorides | 1 | 2008 | 667 | 0.020 |
Why?
|
| Causality | 1 | 2012 | 1275 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2012 | 1147 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 1660 | 0.020 |
Why?
|
| Maryland | 1 | 2006 | 276 | 0.020 |
Why?
|
| Consensus | 1 | 2014 | 2960 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 802 | 0.020 |
Why?
|
| Toxicogenetics | 1 | 2004 | 31 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6896 | 0.020 |
Why?
|
| Calcium Oxalate | 1 | 2005 | 74 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 1222 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2005 | 475 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10183 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5388 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 1475 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2005 | 517 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 11366 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2007 | 794 | 0.010 |
Why?
|
| HIV-1 | 1 | 2021 | 6939 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7730 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2008 | 1061 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2007 | 453 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2011 | 1350 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2011 | 1609 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 1813 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5316 | 0.010 |
Why?
|
| Mediterranean Region | 1 | 2001 | 47 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 1970 | 0.010 |
Why?
|
| Ligands | 1 | 2009 | 3282 | 0.010 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2002 | 63 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5856 | 0.010 |
Why?
|
| Disease Progression | 2 | 2010 | 13286 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3587 | 0.010 |
Why?
|
| Family | 1 | 2012 | 3147 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2014 | 3486 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6313 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4386 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 1541 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1536 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 35425 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2715 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 1219 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4479 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 958 | 0.010 |
Why?
|
| Phylogeny | 1 | 2007 | 2804 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11031 | 0.010 |
Why?
|
| Cholecalciferol | 1 | 2005 | 535 | 0.010 |
Why?
|
| Nevus | 1 | 2001 | 204 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20130 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 780 | 0.010 |
Why?
|
| Health Promotion | 1 | 2011 | 2205 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 2269 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3464 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 1988 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3582 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2002 | 1005 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2005 | 2924 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2017 | 6598 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5077 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7882 | 0.010 |
Why?
|
| Registries | 1 | 2011 | 8091 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2417 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2002 | 1951 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 2988 | 0.010 |
Why?
|
| Proteomics | 1 | 2004 | 3638 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 63107 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16690 | 0.010 |
Why?
|
| Insulin | 1 | 2005 | 6582 | 0.010 |
Why?
|